Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

AstraZeneca In The “Transparency” Era: An Interview With CEO David Brennan

Apr 14 2008

• By Nielsen Hobbs

Related Content

Continuing Medical Education Providers Seek Guidance On Conflict of Interest

Jan 28 2008

Part D Success Will Enhance Pharma’s Political Effectiveness, Execs Predict

Jan 14 2008

To Crestor’s Foe, FDA Says Toxicity Is Low, But DTC Ads Must Go

Mar 21 2005

Lilly Grant Registry Goes Online, Shows $12 Million Dispensed In First Quarter

May 14 2007

AstraZeneca Aims To Grow Seroquel XR With Added Indications, Not Switches

Nov 05 2007

Lilly/Daiichi Submit Prasugrel; Showdown With Plavix Timed For Second Half

Jan 07 2008

PhRMA’s DTC Principles: After Two Years, Still A Work In Progress

Mar 24 2008

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window